LeMaitre Vascular (LMAT) revenue breakdown

Healthcare · Medical Instruments & Supplies · Market cap $1.9B

By region, United States is the largest at 57% of fiscal 2025 revenue; United Kingdom grew fastest, 27% a year over 4 years.

Revenue by region

Fiscal years, as LeMaitre Vascular reports them in its 10-K filings; fiscal 2025 total $250M.

Regions2016201720182019202020212022202320242025Share
United States————$75M$94M$99M$118M$129M$142M 57%
Other countries————$36M$35M$37M$43M$52M$62M 25%
Germany————$12M$13M$11M$13M$14M$18M 7%
Canada————$5M$7M$8M$11M$14M$15M 6%
United Kingdom—————$5M$6M$9M$11M$13M 5%
UNITED STATES———$63M—————— —
UNITED STATES——$59M——————— —
UNITED STATES—$58M———————— —
UNITED STATES$50M————————— —
Other Countries———$42M—————— —
Other Countries——$34M——————— —
Other Countries—$31M———————— —
Other Countries$28M————————— —
GERMANY——$12M——————— —
GERMANY———$12M—————— —
GERMANY—$12M———————— —
GERMANY$10M————————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for LMAT.
Open LMAT in Investingly

Questions

Where does LeMaitre Vascular make its money?

In fiscal 2025, by region: United States $142M, Other countries $62M, Germany $18M, Canada $15M, United Kingdom $13M.

From LeMaitre Vascular's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.